Diabetes 50:1282-1289, 2001
© 2001 by the American Diabetes Association, Inc.
Evidence That Extrapancreatic GLUT2-Dependent Glucose Sensors Control Glucagon Secretion
Rémy Burcelin, and
Bernard Thorens
Institute of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland
GLUT2-/- mice reexpressing GLUT1 or GLUT2 in their ß-cells (RIPGLUT1 x GLUT2-/- or RIPGLUT2 x GLUT2-/- mice) have nearly normal glucose-stimulated insulin secretion but show high glucagonemia in the fed state. Because this suggested impaired control of glucagon secretion, we set out to directly evaluate the control of glucagonemia by variations in blood glucose concentrations. Using fasted RIPGLUT1 x GLUT2-/- mice, we showed that glucagonemia was no longer increased by hypoglycemic (2.5 mmol/l glucose) clamps or suppressed by hyperglycemic (10 and 20 mmol/l glucose) clamps. However, an increase in plasma glucagon levels was detected when glycemia was decreased to 1 mmol/l, indicating preserved glucagon secretory ability, but of reduced sensitivity to glucopenia. To evaluate whether the high-fed glucagonemia could be due to an abnormally increased tone of the autonomic nervous system, fed mutant mice were injected with the ganglionic blockers hexamethonium and chlorisondamine. Both drugs lead to a rapid return of glucagonemia to the levels found in control fed mice. We conclude that 1) in the absence of GLUT2, there is an impaired control of glucagon secretion by low or high glucose; 2) this impaired glucagon secretory activity cannot be due to absence of GLUT2 from -cells because these cells do not normally express this transporter; 3) this dysregulation may be due to inactivation of GLUT2-dependent glucose sensors located outside the endocrine pancreas and controlling glucagon secretion; and 4) because fed hyperglucagonemia is rapidly reversed by ganglionic blockers, this suggests that in the absence of GLUT2, there is an increased activity of the autonomic nervous system stimulating glucagon secretion during the fed state.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Marty, M. Dallaporta, and B. Thorens
Brain Glucose Sensing, Counterregulation, and Energy Homeostasis
Physiology,
August 1, 2007;
22(4):
241 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev.,
February 1, 2007;
28(1):
84 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Marty, I. Bady, and B. Thorens
Distinct Classes of Central GLUT2-Dependent Sensors Control Counterregulation and Feeding
Diabetes,
December 1, 2006;
55(Supplement_2):
S108 - S113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bady, N. Marty, M. Dallaporta, M. Emery, J. Gyger, D. Tarussio, M. Foretz, and B. Thorens
Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding.
Diabetes,
April 1, 2006;
55(4):
988 - 995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takahashi, H. Ishihara, A. Tamura, S. Yamaguchi, T. Yamada, D. Takei, H. Katagiri, H. Endou, and Y. Oka
Cell type-specific activation of metabolism reveals that {beta}-cell secretion suppresses glucagon release from {alpha}-cells in rat pancreatic islets
Am J Physiol Endocrinol Metab,
February 1, 2006;
290(2):
E308 - E316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bertelli and M. Bendayan
Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development?
J. Histochem. Cytochem.,
September 1, 2005;
53(9):
1071 - 1086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sandu, K. Song, W. Cai, F. Zheng, J. Uribarri, and H. Vlassara
Insulin Resistance and Type 2 Diabetes in High-Fat-Fed Mice Are Linked to High Glycotoxin Intake
Diabetes,
August 1, 2005;
54(8):
2314 - 2319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim
{beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release
Diabetes,
June 1, 2005;
54(6):
1808 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson
Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis
Diabetes,
June 1, 2004;
53(6):
1488 - 1495.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|